# Lactate regulates the YTHDF2-FTH1 axis to promote cardiomyocyte ferroptosis and aggravate myocardial ischemia-reperfusion injury

**Authors:** Zhonghao Xiang, Bitao Xiang, Tianyu Ouyang, Yadong Long, Chengliang Zhang

PMC · DOI: 10.1038/s41598-026-35130-3 · 2026-01-08

## TL;DR

Lactate promotes heart cell death through a specific protein interaction, worsening heart damage after blood flow is restored.

## Contribution

The study reveals a novel mechanism where lactate-induced YTHDF2 lactylation promotes cardiomyocyte ferroptosis in myocardial ischemia-reperfusion injury.

## Key findings

- Lactate levels increase in MI/R hearts, correlating with structural damage and elevated Fe²⁺ and CK-MB levels.
- YTHDF2 lactylation by lactate reduces FTH1 mRNA stability, promoting ferroptosis in cardiomyocytes.
- Knockdown of YTHDF2 suppresses ferroptosis, an effect reversed by FTH1 reduction.

## Abstract

Myocardial ischemia–reperfusion (MI/R) injury remains a major clinical challenge, and ferroptosis has recently emerged as a crucial contributor to its pathogenesis. However, the regulatory mechanisms underlying ferroptosis in MI/R remain incompletely understood. Here, we investigated the role of lactate-mediated YTHDF2 regulation in cardiomyocyte ferroptosis. A murine ischemia–reperfusion (I/R) model and an H9C2 hypoxia/reoxygenation (H/R) model were established. Biochemical assays revealed elevated lactate levels in MI/R hearts, accompanied by increased infarct size, enhanced structural damage, and elevated Fe²⁺ and creatine kinase-MB (CK-MB) levels. Lactate treatment promoted YTHDF2 lactylation and upregulated its expression in cardiomyocytes. Mechanistically, YTHDF2 bound to ferritin heavy chain 1 (FTH1) mRNA and reduced its stability through m6A-dependent degradation, thereby promoting ferroptosis. Knockdown of YTHDF2 suppressed ferroptosis, an effect reversed by FTH1 reduction. These findings identify lactate-induced YTHDF2 lactylation as a key driver of cardiomyocyte ferroptosis and reveal a novel mechanism exacerbating MI/R injury, suggesting that targeting this pathway may represent a potential therapeutic strategy.

The online version contains supplementary material available at 10.1038/s41598-026-35130-3.

## Linked entities

- **Genes:** YTHDF2 (YTH N6-methyladenosine RNA binding protein F2) [NCBI Gene 51441], FTH1 (ferritin heavy chain 1) [NCBI Gene 2495]
- **Proteins:** FTH1 (ferritin heavy chain 1)
- **Chemicals:** lactate (PubChem CID 61503)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** YTHDF2 (YTH N6-methyladenosine RNA binding protein F2) [NCBI Gene 51441] {aka CAHL, DF2, HGRG8, NY-REN-2}, FTH1 (ferritin heavy chain 1) [NCBI Gene 2495] {aka FHC, FTH, FTHL6, HFE5, NBIA9, PIG15}
- **Diseases:** myocardial ischemia (MESH:D017202), reperfusion injury (MESH:D015427)
- **Chemicals:** Lactate (MESH:D019344)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12873153/full.md

---
Source: https://tomesphere.com/paper/PMC12873153